先請小扒(Bard)來幫忙 What is “Regina Elena National Cancer Institute, Rome, Italy”
Answer:
The Regina Elena National Cancer Institute (IRE) is a leading cancer research and treatment center in Italy. It is located in Rome and has been operating since 1933. The IRE is a comprehensive cancer center, which means that it offers a wide range of cancer services, including: Clinical care, Research, Education and training, Prevention and early detection, Supportive care
The IRE is a member of the Organisation of European Cancer Institutes (OECI) and has been accredited as a Comprehensive Cancer Center. This means that it meets the highest international standards for cancer care.
The IRE is a major research center and has been involved in many important cancer research breakthroughs. The institute has also developed several innovative cancer treatments, including proton therapy and immunotherapy.
The IRE is also a major training center for cancer professionals. It offers a variety of educational programs for doctors, nurses, and other healthcare workers.
The IRE is a world-renowned cancer center and provides excellent care to patients from all over Italy and the world.
Here are some additional information about the IRE from the search results:
The IRE has over 2,000 employees and treats over 30,000 patients each year.
The IRE has a 100-bed hospital and a number of outpatient clinics.
The IRE has a strong research program and has published over 10,000 scientific papers.
The IRE is a member of the European Organisation for Research and Treatment of Cancer (EORTC).
Journal of Experimental & Clinical Cancer Research (JECCR) 乃其官方雜誌，2008年為BMC出版社所收錄，總編道出願景：
- Topics considered range from molecular genetics via infectious agents to surgery and therapeutic approaches and outcomes.
- The broad oncological focus, combined with the Editors’ experience in evaluating and conducting systematic reviews and developing clinical practice guidelines, makes JECCR an attractive forum for publishing reviews and guidelines.
- This focus, well documented in an Editorial by H. J. Schünemann [4], goes very well together with the approach now being widely applied by many international and national organizations, including the World Health Organization (WHO), Cochrane Collaboration, American College of Physicians (ACP), and the National Institutes for Health and Clinical Excellence in the U.K. (NICE).